Australian Company Vaxxas Successfully Manufactures Vaccines Patches

Australian Company Vaxxas Successfully Manufactures Vaccines Patches
SHARE

The Covid-19 pandemic caught the world off guard and governments were not prepared for the crisis. Although vaccines were developed in just one year, their distribution was initially limited and inefficient. However, new technology has made it easier to distribute painless vaccines. According to Deputy Premier Steven Miles, expanding our capability to develop, manufacture, and deliver vaccines is a crucial lesson we learned from the pandemic. He believes this new technology will play a critical role in pandemic preparedness, making it possible to quickly and easily deploy vaccines to our communities.

New painless patches

According to New Atlas, the technology behind the novel vaccine patch was developed at the University of Queensland in 2011. Researchers utilized the blueprint of the dry-delivery microneedle/microarray research to create the patch.

New Atlas journalist Bronwyn Thompson reported that the patch contains thousands of tiny, dry vaccine-coated micro projections that painlessly deliver the drug to immune cells just below the skin’s surface when they come into contact with it.

Furthermore, the Vaxxas facility will launch the Queensland Biomedical Business Attraction Program, which aims to attract interstate and international industries to access the biomedical capability of the state.

Vaxxas CEO David Hoey stated that within three to five years, the plant is expected to manufacture and distribute the first commercially available needle-free vaccine patches.

The Queensland government claims that this novel vaccine patch technology can deposit a vaccine through the skin’s surface in a matter of seconds.

Government-backed “vaccines”

The Palaszczuk government is backing the Vaxxas project, which is set to become the leading venture in boosting the economy of the state. According to the government, the Vaxxas project is in line with the Biomedical 10-Year Roadmap and Action Plan of Queensland. The biomedical sector contributes $2.1 billion to the economy of the state and provides employment to over 12,000 individuals.

Queensland deputy premier Steven Miles has stated that the Palaszczuk government is committed to supporting local biomedical start-ups to grow successfully and ensure that innovation and the best researchers remain in the state.

We suggest that you check out the complete original article in order to learn more details about this.


SHARE
Rada Mateescu

Passionate about freedom, truth, humanity, and subjects from the science and health-related areas, Rada has been blogging for about ten years, and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.